FI891098A - Magnetiska proteinkonjugater, foerfarande foer deras framstaellning och deras anvaendning. - Google Patents

Magnetiska proteinkonjugater, foerfarande foer deras framstaellning och deras anvaendning. Download PDF

Info

Publication number
FI891098A
FI891098A FI891098A FI891098A FI891098A FI 891098 A FI891098 A FI 891098A FI 891098 A FI891098 A FI 891098A FI 891098 A FI891098 A FI 891098A FI 891098 A FI891098 A FI 891098A
Authority
FI
Finland
Prior art keywords
deras
conjugater
foerfarande foer
protein
anvaendning
Prior art date
Application number
FI891098A
Other languages
English (en)
Other versions
FI102077B1 (fi
FI102077B (fi
FI891098A0 (fi
Inventor
Peter Hermentin
Reiner Doenges
Karlheinz Enssle
Roland Kurrle
Friedrich Robert Seiler
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of FI891098A0 publication Critical patent/FI891098A0/fi
Publication of FI891098A publication Critical patent/FI891098A/fi
Application granted granted Critical
Publication of FI102077B1 publication Critical patent/FI102077B1/fi
Publication of FI102077B publication Critical patent/FI102077B/fi

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6889Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K17/00Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02Peptides being immobilised on, or in, an organic carrier
    • C07K17/06Peptides being immobilised on, or in, an organic carrier attached to the carrier via a bridging agent
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081Purging biological preparations of unwanted cells
    • C12N5/0087Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326Magnetic particles
    • G01N33/5434Magnetic particles using magnetic particle immunoreagent carriers which constitute new materials per se
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00Magnetic particle immunoreagent carriers
    • G01N2446/80Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids
    • G01N2446/90Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids characterised by small molecule linker used to couple immunoreagents to magnetic particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI891098A 1988-03-10 1989-03-08 Magneettisia proteiinikonjugaatteja, menetelmä niiden valmistamiseksi ja niiden käyttö FI102077B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3807904A DE3807904A1 (de) 1988-03-10 1988-03-10 Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung
DE3807904 1988-03-10

Publications (4)

Publication Number Publication Date
FI891098A0 FI891098A0 (fi) 1989-03-08
FI891098A true FI891098A (fi) 1989-09-11
FI102077B1 FI102077B1 (fi) 1998-10-15
FI102077B FI102077B (fi) 1998-10-15

Family

ID=6349346

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891098A FI102077B (fi) 1988-03-10 1989-03-08 Magneettisia proteiinikonjugaatteja, menetelmä niiden valmistamiseksi ja niiden käyttö

Country Status (13)

Country Link
US (1) US5672687A (fi)
EP (1) EP0332022B1 (fi)
JP (1) JP2756297B2 (fi)
KR (1) KR0142876B1 (fi)
AT (1) ATE114667T1 (fi)
AU (1) AU626540B2 (fi)
CA (1) CA1339199C (fi)
DE (2) DE3807904A1 (fi)
DK (1) DK114689A (fi)
ES (1) ES2064373T3 (fi)
FI (1) FI102077B (fi)
PT (1) PT89963B (fi)
YU (1) YU49189A (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62197425A (ja) * 1986-02-25 1987-09-01 Toyo Soda Mfg Co Ltd 球状熱可塑性樹脂の製造方法
US5169754A (en) * 1990-10-31 1992-12-08 Coulter Corporation Biodegradable particle coatings having a protein covalently immobilized by means of a crosslinking agent and processes for making same
EP0772776B1 (de) * 1994-07-27 2000-03-22 Herbert Dr. Pilgrimm Superparamagnetische teilchen, verfahren zur herstellung und deren verwendung
WO2001020042A2 (en) * 1999-09-15 2001-03-22 Miraibio Inc. Method for processing biological samples
JP2003514773A (ja) * 1999-09-28 2003-04-22 ウニヴェルジテート チューリッヒ 血清及び血漿中のプリオン結合活性を有する因子並びに伝染性海綿状脳障害を検出するための薬剤
DE10108857A1 (de) * 2001-02-14 2002-09-19 Hans-Dieter Hunger Bioaktive und biokompatible Konjugate mit magnetischen Eigenschaften und Verfahren zu deren Herstellung
EP1419786A1 (en) 2002-11-13 2004-05-19 Bracco Imaging S.p.A. Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof
US7164010B1 (en) 2005-09-28 2007-01-16 Academia Sinica Molecular magnetic protein
WO2012012737A2 (en) 2010-07-23 2012-01-26 The University Of Toledo Stable tregs and related materials and methods
CN113049811A (zh) * 2021-03-22 2021-06-29 深圳市亚辉龙生物科技股份有限公司 纳米磁珠包被物及其制备方法、检测试剂和检测试剂盒

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4671958A (en) * 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
FR2523445A1 (fr) * 1982-03-17 1983-09-23 Sanofi Sa Nouveaux conjugues associant, par liaison covalente, une enzyme et un anticorps, et associations medicamenteuses utilisant lesdits conjugues
NO155316C (no) * 1982-04-23 1987-03-11 Sintef Fremgangsmaate for fremstilling av magnetiske polymerpartikler.
EP0109653A3 (en) * 1982-11-17 1986-01-29 Otsuka Pharmaceutical Co., Ltd. Process for preparing urokinase complex
JPS59134763A (ja) * 1983-01-20 1984-08-02 Eisai Co Ltd セクレチン関連誘導体
US4735796A (en) * 1983-12-08 1988-04-05 Gordon Robert T Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
NO163600C (no) * 1983-04-13 1990-06-27 Chem Fab Corp Forsterket fluorpolymer-komposittmateriale.
US4698302A (en) * 1983-05-12 1987-10-06 Advanced Magnetics, Inc. Enzymatic reactions using magnetic particles
US4554088A (en) * 1983-05-12 1985-11-19 Advanced Magnetics Inc. Magnetic particles for use in separations
US4659839A (en) * 1984-10-10 1987-04-21 Mallinckrodt, Inc. Coupling agents for radiolabeled antibody fragments
US4795698A (en) * 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
US5002883A (en) * 1987-10-30 1991-03-26 Abbott Laboratories Covalent attachment of antibodies and antigens to solid phases using extended length heterobifunctional coupling agents

Also Published As

Publication number Publication date
PT89963A (pt) 1989-11-10
DE3807904A1 (de) 1989-09-21
DK114689A (da) 1989-09-11
ATE114667T1 (de) 1994-12-15
KR0142876B1 (ko) 1998-07-01
KR890014471A (ko) 1989-10-23
DE3807904C2 (fi) 1992-02-20
EP0332022B1 (de) 1994-11-30
DE58908667D1 (de) 1995-01-12
EP0332022A2 (de) 1989-09-13
JPH02152997A (ja) 1990-06-12
AU626540B2 (en) 1992-08-06
AU3113589A (en) 1989-09-14
JP2756297B2 (ja) 1998-05-25
CA1339199C (en) 1997-08-05
FI102077B1 (fi) 1998-10-15
FI102077B (fi) 1998-10-15
FI891098A0 (fi) 1989-03-08
EP0332022A3 (de) 1991-07-17
YU49189A (en) 1991-08-31
ES2064373T3 (es) 1995-02-01
PT89963B (pt) 1994-05-31
DK114689D0 (da) 1989-03-09
US5672687A (en) 1997-09-30

Similar Documents

Publication Publication Date Title
NZ241217A (en) Acid-labile linker compounds derived from maleamic acids.
FI891098A0 (fi) Magnetiska proteinkonjugater, foerfarande foer deras framstaellning och deras anvaendning.
EP0180564A3 (en) Immunogenic complex, a method for producing the same, and the use thereof as an immune stimulant, vaccines and reagents
GB1527152A (en) Transplants
DK592489A (da) Glycosphingolipider, deres fremstillng og anvendelse
DE68926991D1 (de) Verfahren zum Nachweis und zur Identifizierung von Nukleinsäure enthaltenden Teilen
ATE235506T1 (de) Behandlung einer proteinlösung mit a1/fe und anschliesende membrankonzentration
DK0403961T3 (da) Magnetiske protein-konjugater, fremgangsmåde til deres fremstilling og deres anvendelse
DE69230970D1 (de) Bicylclische, polyazamakrocyclocarbonsäure-komplexe, konjugate, herstellung und verwendung als kontraststoffe
FI883602A0 (fi) Menetelmä (7S,9S)-9-asetyyli-9-amino-7-/(2-deoksi- -D-erytro-pentopyranosyyli)oksi/-7,8,9,10-tetrahydro-6,11-dihydroksi-naftaseeni-5,12-dionia tai sen suolaa sisältävän stabiilin valmisteen valmistamiseksi
FR2634023B1 (fr) Reactif sous forme de support solide permettant de fixer par covalence un ligand biologique amine, sa preparation et son utilisation
DE59010462D1 (de) Neue Cobalamin-Säurehydrazide und davon abgeleitete Cobalamin-Konjugate
EP0974598A3 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments
IE902195L (en) Magnetic protein conjugates
DE69033306D1 (de) Proteinkomplex
GB1508922A (en) Method for obtaining urokinase
HU0103997D0 (en) Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines
TH37947A (th) ไกลโคคอนจูเกตของ 20 (s) - แคมปโตธีซิน

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: DADE BEHRING MARBURG GMBH

MM Patent lapsed

Owner name: DADE BEHRING MARBURG GMBH